vs

Side-by-side financial comparison of AMES NATIONAL CORP (ATLO) and IRIDEX CORP (IRIX). Click either name above to swap in a different company.

AMES NATIONAL CORP is the larger business by last-quarter revenue ($18.7M vs $14.7M, roughly 1.3× IRIDEX CORP). On growth, AMES NATIONAL CORP posted the faster year-over-year revenue change (26.7% vs -69.7%). Over the past eight quarters, AMES NATIONAL CORP's revenue compounded faster (19.5% CAGR vs 11.9%).

Ames National Corp is a U.S. financial holding company based in Iowa. It operates multiple community banking subsidiaries, offering retail and commercial financial services including deposit accounts, personal and business loans, mortgages, and wealth management, primarily serving consumers and SMEs across central Iowa.

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

ATLO vs IRIX — Head-to-Head

Bigger by revenue
ATLO
ATLO
1.3× larger
ATLO
$18.7M
$14.7M
IRIX
Growing faster (revenue YoY)
ATLO
ATLO
+96.4% gap
ATLO
26.7%
-69.7%
IRIX
Faster 2-yr revenue CAGR
ATLO
ATLO
Annualised
ATLO
19.5%
11.9%
IRIX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ATLO
ATLO
IRIX
IRIX
Revenue
$18.7M
$14.7M
Net Profit
$6.5M
Gross Margin
37.2%
Operating Margin
44.3%
Net Margin
34.9%
Revenue YoY
26.7%
-69.7%
Net Profit YoY
85.4%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATLO
ATLO
IRIX
IRIX
Q4 25
$18.7M
$14.7M
Q3 25
$16.6M
$12.5M
Q2 25
$16.1M
$13.6M
Q1 25
$15.5M
$11.9M
Q4 24
$14.7M
$12.7M
Q3 24
$13.5M
$11.6M
Q2 24
$13.5M
$12.6M
Q1 24
$13.1M
$11.8M
Net Profit
ATLO
ATLO
IRIX
IRIX
Q4 25
$6.5M
Q3 25
$4.6M
$-1.6M
Q2 25
$4.5M
$-994.0K
Q1 25
$3.4M
$-1.7M
Q4 24
$3.5M
$-834.0K
Q3 24
$2.2M
$-1.9M
Q2 24
$2.2M
$-2.7M
Q1 24
$2.3M
$-3.5M
Gross Margin
ATLO
ATLO
IRIX
IRIX
Q4 25
37.2%
Q3 25
32.1%
Q2 25
34.5%
Q1 25
42.5%
Q4 24
44.0%
Q3 24
37.3%
Q2 24
40.7%
Q1 24
37.9%
Operating Margin
ATLO
ATLO
IRIX
IRIX
Q4 25
44.3%
Q3 25
34.5%
-11.3%
Q2 25
35.0%
-6.9%
Q1 25
27.4%
-1.7%
Q4 24
29.4%
-3.9%
Q3 24
19.4%
-16.1%
Q2 24
19.0%
-20.9%
Q1 24
20.8%
-28.0%
Net Margin
ATLO
ATLO
IRIX
IRIX
Q4 25
34.9%
Q3 25
27.5%
-12.6%
Q2 25
28.0%
-7.3%
Q1 25
22.3%
-14.2%
Q4 24
23.8%
-6.6%
Q3 24
16.4%
-16.7%
Q2 24
16.2%
-21.2%
Q1 24
17.6%
-29.5%
EPS (diluted)
ATLO
ATLO
IRIX
IRIX
Q4 25
Q3 25
$-0.09
Q2 25
$-0.06
Q1 25
$-0.10
Q4 24
$-0.05
Q3 24
$-0.12
Q2 24
$-0.16
Q1 24
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATLO
ATLO
IRIX
IRIX
Cash + ST InvestmentsLiquidity on hand
$126.8M
$6.0M
Total DebtLower is stronger
$18.4M
Stockholders' EquityBook value
$207.9M
Total Assets
$2.1B
$29.2M
Debt / EquityLower = less leverage
0.09×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATLO
ATLO
IRIX
IRIX
Q4 25
$126.8M
$6.0M
Q3 25
$108.2M
$5.6M
Q2 25
$95.2M
$6.8M
Q1 25
$163.4M
$7.2M
Q4 24
$101.2M
$2.4M
Q3 24
$59.0M
$3.9M
Q2 24
$63.4M
$4.1M
Q1 24
$111.4M
$5.4M
Total Debt
ATLO
ATLO
IRIX
IRIX
Q4 25
$18.4M
Q3 25
Q2 25
Q1 25
Q4 24
$20.0M
$1.0M
Q3 24
$1.4M
Q2 24
Q1 24
Stockholders' Equity
ATLO
ATLO
IRIX
IRIX
Q4 25
$207.9M
Q3 25
$200.6M
$4.7M
Q2 25
$193.0M
$6.1M
Q1 25
$183.1M
$852.0K
Q4 24
$174.7M
$2.1M
Q3 24
$183.4M
$2.6M
Q2 24
$167.1M
$4.2M
Q1 24
$165.5M
$6.5M
Total Assets
ATLO
ATLO
IRIX
IRIX
Q4 25
$2.1B
$29.2M
Q3 25
$2.1B
$28.4M
Q2 25
$2.1B
$31.6M
Q1 25
$2.2B
$34.2M
Q4 24
$2.1B
$29.1M
Q3 24
$2.1B
$30.2M
Q2 24
$2.1B
$31.2M
Q1 24
$2.2B
$34.1M
Debt / Equity
ATLO
ATLO
IRIX
IRIX
Q4 25
0.09×
Q3 25
Q2 25
Q1 25
Q4 24
0.11×
0.48×
Q3 24
0.53×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATLO
ATLO
IRIX
IRIX
Operating Cash FlowLast quarter
$21.3M
Free Cash FlowOCF − Capex
$20.7M
FCF MarginFCF / Revenue
110.8%
Capex IntensityCapex / Revenue
3.4%
Cash ConversionOCF / Net Profit
3.28×
TTM Free Cash FlowTrailing 4 quarters
$34.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATLO
ATLO
IRIX
IRIX
Q4 25
$21.3M
Q3 25
$2.8M
$-1.2M
Q2 25
$4.0M
$-397.0K
Q1 25
$7.1M
$-1.1M
Q4 24
$14.3M
$-1.2M
Q3 24
$3.1M
$-3.1M
Q2 24
$3.9M
$-1.3M
Q1 24
$1.4M
$-1.6M
Free Cash Flow
ATLO
ATLO
IRIX
IRIX
Q4 25
$20.7M
Q3 25
$2.6M
$-1.2M
Q2 25
$3.9M
$-410.0K
Q1 25
$6.9M
$-1.2M
Q4 24
$14.0M
$-1.2M
Q3 24
$3.0M
$-3.1M
Q2 24
$3.8M
Q1 24
$1.3M
$-1.7M
FCF Margin
ATLO
ATLO
IRIX
IRIX
Q4 25
110.8%
Q3 25
16.0%
-9.4%
Q2 25
24.2%
-3.0%
Q1 25
44.8%
-9.8%
Q4 24
94.9%
-9.8%
Q3 24
22.5%
-26.5%
Q2 24
28.1%
Q1 24
10.0%
-14.0%
Capex Intensity
ATLO
ATLO
IRIX
IRIX
Q4 25
3.4%
Q3 25
0.6%
0.1%
Q2 25
0.7%
0.1%
Q1 25
1.3%
0.1%
Q4 24
2.0%
0.1%
Q3 24
0.5%
0.0%
Q2 24
0.7%
0.0%
Q1 24
0.5%
0.0%
Cash Conversion
ATLO
ATLO
IRIX
IRIX
Q4 25
3.28×
Q3 25
0.60×
Q2 25
0.89×
Q1 25
2.07×
Q4 24
4.07×
Q3 24
1.40×
Q2 24
1.78×
Q1 24
0.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons